Home Nav
Nextech Invest Logo

Karl-Heinz Altmann

Alfred Scheidegger

Karl-Heinz Altmann PhD is professor of pharmaceutical sciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. He has been a senior scientific expert in chemistry, global head of Discovery Chemistry, member of the Pharma Research Management Board and head of the Scientific Chemistry Council, Novartis Ltd., and serves as a consultant to several pharmaceutical companies.

 

Swiss Biotech Day

04.05.2017

Basel

  • 20.04.2017

    Jounce Therapeutics initiates Phase 2 portion of ICONIC...

  • 19.04.2017

    Kura Oncology granted U.S. patent for clinical-stage...

  • 10.04.2017

    Tracon awarded 'Most Innovative Trial Design' for Phase...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close